NCT03070509View on ClinicalTrials.gov

Pharmacokinetics of Lisdexamfetamine (Vyvanse®) in Post-bariatric Surgery Patients

PHASE4UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 12, 2017

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Lisdexamfetamine
Interventions
DRUG

Lisdexamfetamine

lisdexamfetamine 50 mg single dose

Trial Locations (1)

58103

RECRUITING

Neuropsychiatric Research Institute, Fargo

Sponsors

Collaborators (1)

Shire
All Listed Sponsors
collaborator

Shire

INDUSTRY

collaborator

Neuropsychiatric Research Institute, Fargo, North Dakota

OTHER

lead

North Dakota State University

OTHER